Knowledge Action Portal on NCDs

1 Resources
Short
<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--news-and-events.html.twig ✅ field--node--title.html.twig ▪️ field--node--news-and-events.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> MPP signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

Medicines Patent Pool

MPP signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia

..

News

02 Sep 2024
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Read More